Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine
Abstract
The therapeutic activity of rimantadine and its relationship to the shedding of drug-resistant influenza A virus were assessed in two randomized, double-blind, placebo-controlled trials involving patients with laboratory-documented influenza A virus (H3N2 subtype) illness of 2 days' duration or less …
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
u.s. gov't
non-p.h.s.
adult
female
male
adolescent
middle aged
Child
Infant
P.H.S.
preschool
Clinical Trial
Randomized Controlled Trial
drug resistance
microbial
drug evaluation
influenza
human / drug therapy*
influenza a virus / drug effects
influenza a virus / isolation & purification*
f g hayden
rimantadine / therapeutic use*
pmid:1952841
pmc245261
doi:10.1128/aac.35.9.1741
s j sperber
s pyke
Access
Citation
ID:
271652
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
271652
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet